Document resource
Prostate specific antigen screening reduces the risk of death from prostate cancer by 13%, one of the largest randomised studies of its kind concludes.1
Annotated abstract
PSA screening cuts cancer mortality by 13%, study shows, amid debate about national programme
bmj · 2025-10-30 · canonical JSON source